Reliance Chemotex Industries Reports 42.8% Revenue Surge in Q1 FY2026
Reliance Chemotex, a synthetic blended yarn manufacturer, announced robust Q1 FY2026 results. Total income increased by 42.8% to ₹92.75 crore, while net profit rose 15.2% to ₹1.06 crore. EBITDA saw a significant 180.9% growth to ₹8.51 crore. EPS improved to ₹1.41. The Board of Directors approved these unaudited results on August 14, 2025, which were prepared according to Indian Accounting Standards and published in newspapers on August 15, 2025.

*this image is generated using AI for illustrative purposes only.
Reliance Chemotex , a leading synthetic blended yarn manufacturer based in Udaipur, Rajasthan, has announced robust financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.
Strong Revenue Growth
The company reported a substantial increase in total income, which rose by 42.8% year-on-year to ₹92.75 crore in Q1 FY2026, compared to ₹64.93 crore in the same quarter of the previous year. This impressive growth underscores the company's strong market position and effective business strategies.
Profitability and Operational Performance
Reliance Chemotex saw a notable improvement in its bottom line, with net profit rising by 15.2% to ₹1.06 crore, up from ₹0.92 crore in Q1 FY2025. This growth in profitability reflects the company's ability to manage costs effectively while expanding its revenue base.
The company's operational performance showed remarkable progress, with EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) registering a significant growth of 180.9%. EBITDA for Q1 FY2026 stood at ₹8.51 crore, compared to ₹3.03 crore in the corresponding quarter of the previous year, indicating substantial improvement in operational efficiency and cost management.
Key Financial Highlights
Metric | Q1 FY2026 | Q1 FY2025 | YoY Change |
---|---|---|---|
Total Income | 92.75 | 64.93 | +42.8% |
Net Profit | 1.06 | 0.92 | +15.2% |
EBITDA | 8.51 | 3.03 | +180.9% |
Basic & Diluted EPS | 1.41 | 1.22 | +15.6% |
Earnings Per Share
The earnings per share (EPS) for both basic and diluted categories improved to ₹1.41 in Q1 FY2026, up from ₹1.22 in the same period last year, reflecting the positive impact of the company's performance on shareholder value.
Management Approval and Compliance
The unaudited financial results were approved by the Board of Directors of Reliance Chemotex in their meeting held on August 14, 2025. The results have been prepared in accordance with Indian Accounting Standards, ensuring compliance with regulatory requirements.
Transparency and Disclosure
In line with regulatory requirements, the company has published its financial results in both English and Hindi newspapers, specifically in the Financial Express and Jai Rajasthan, on August 15, 2025. This demonstrates Reliance Chemotex's commitment to transparency and timely disclosure of financial information to its stakeholders.
The detailed financial results are available on the company's website at www.reliancechemotex.com , providing easy access for investors and analysts to review the company's performance.
Reliance Chemotex's strong performance in Q1 FY2026 reflects its resilience and ability to capitalize on market opportunities. The significant growth in revenue and profitability positions the company well for continued success in the synthetic yarn manufacturing sector.
Historical Stock Returns for Reliance Chemotex
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+0.12% | +1.22% | -4.18% | +1.03% | -28.38% | -28.37% |